Skip to content

Iyengar Yoga for Young People With Rheumatoid Arthritis

Iyengar Yoga for Young People With Rheumatoid Arthritis

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01096823
Enrollment
30
Registered
2010-03-31
Start date
2009-06-30
Completion date
2011-05-31
Last updated
2016-04-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Rheumatoid Arthritis

Keywords

Rheumatoid Arthritis, Yoga, Adolescents, Young Adults

Brief summary

The purpose of this study is to compare a standardized 6 week Iyengar Yoga program (IYP) for adolescents and young adults with rheumatoid arthritis to a standard care wait-list condition. In addition to effects on function and pain, this study will explore intervention effects on disease activity, immune response, HRQOL, functionality, and mood. Results will shed light on the feasibility and potential efficacy of a novel intervention (Iyengar yoga) for rheumatoid arthritis symptoms. The hypotheses are: 1. The IYP will be safe, acceptable and feasible: at least 80% of subjects will complete the IYP. 2. Following the IYP, participants will show significantly improved disease status, general functioning, arthritis-functioning and HRQOL relative to controls. The benefits will be apparent post-treatment and at two-month follow-up. 3. Following the IYP, participants will report significantly improved pain, immune response and mood compared to controls. These improvements will be evident at both post-treatment and at two-month follow-up.

Interventions

BEHAVIORALIyengar Yoga

Iyengar Yoga classes twice a week for six weeks

Sponsors

University of California, Los Angeles
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
16 Years to 35 Years
Healthy volunteers
No

Inclusion criteria

* People with rheumatoid arthritis between the ages of 16-35 * Diagnosis of RA, according to the revised 1987 ACR criteria, or juvenile idiopathic arthritis (JIA) for at least 6 months * Concomitant use of disease modifying antirheumatic medications (hydroxychloroquine, sulfasalazine, methotrexate, leflunomide, etc) biologic agents (infliximab, etanercept, adalimumab, abatacept, rituximab, anakinra) is permitted provided that the dose(s) have been stable for 4 weeks prior to screening, and may reasonably be expected to remain on stable doses throughout the duration of the trial * Concomitant use of non-steroidal anti-inflammatory drugs (NSAIDs) and low dose corticosteroids (e.g prednisone at doses of 10 /day prednisone or equivalent is permitted provided that the dose(s) have been stable for 4 weeks prior to screening, and may reasonably be expected to remain on stable doses throughout the duration of the trial * Disease activity, as defined using a 28 joint count by \> 5 tender joints, \> 5 swollen joints, and one of the following: ESR \> 28 mm/hour, CRP \> 1.5 mg/dL, duration of a.m. stiffness \> 45 minutes * Ability to provide written informed consent * Ability to speak and understand English

Exclusion criteria

* Intra-articular steroid injections within 4 weeks of screening * Treatment with any investigational agent within 8 weeks of screening or 5 half-lives of the investigational drug (whichever is longer) * History of drug, alcohol, or chemical abuse within 6 months prior to screening * Any other disease, metabolic dysfunction, physical examination finding, or clinical laboratory finding giving reasonable suspicion that might affect the interpretation of the results or render the patient at high risk from treatment complications * Inability to comply with study and follow-up procedures * Currently pregnant * Inability to speak or understand English * Any recent injury.

Design outcomes

Primary

MeasureTime frameDescription
Health Related Quality of Life - Short Form-36 (SF-36)post intervention (within 2 weeks of completing intervention)The Health Related Quality of Life - Short Form-36 (SF-36) is a generic core HRQOL measure yielding an 8-scale profile of functional health and well being. The SF-36 performs comparatively better than other HRQOL measures in terms of reliability, validity, lightness of respondent/administrative burden. It can be completed in 5-10 minutes and has been used with children as young as 10 years of age. Subscales - all ranges 0-100 with higher scores indicating increased quality of life Bodily Pain, 2 items General Health, 5 items Vitality, 4 items Mental Health, 5 items
Pain Disability Index (PDI)post intervention (within 2 weeks of completing intervention)The PDI assess the impact of pain on ability to participate in basic life activities, including social activity, sexual behavior, self-care and life-support activity. The PDI has been used with patients as young as 15. Good internal reliability (α = .82) and validity have been reported. It takes less than 5 minutes to complete. 7 items, total measure range: 0-70, higher scores = higher interference/disability
Health Assessment Questionnaire (HAQ)post intervention (within 2 weeks of completing intervention)Items include questions about dressing and grooming, rising, eating, walking, hygiene, reaching, grip and making activities. The HAQ is one of the most widely recognized measures of patient functioning, with acceptable reliability and validity. It has been used successfully with adolescents as young as 13 years of age Range: 0-100, lower scores indicate better health
Disease Activity Scale (DAS)28post intervention (within 2 weeks of completing intervention)is a combined index that measures disease activity in patients with RA and remains a more thorough, established alternative to standard medical exams. This index includes a 28 tender joint count, 28 swollen joint count, Erythrocyte Sedimentation Rate (ESR), and general health assessment using a visual analogue scale. The ESR indirectly measures inflammation in the body and involves collecting blood samples, which will be performed by a qualified phlebotomist. The DAS score is a complicated formula based on many factors so there are no set ranges, but the published standards are as follows: A DAS28 score of higher than 5.1 is indicative of high disease activity, whereas a DAS28 below 3.2 indicates low disease activity. A patient is considered to be in remission if they have a DAS28 lower than 2.6. Source: DAS-Score.nl. Available at http://www.das-score.nl/www.das-score.nl/index.html. Accessed February 5, 2009.

Countries

United States

Participant flow

Participants by arm

ArmCount
Iyengar Yoga
Iyengar Yoga: Iyengar Yoga classes twice a week for six weeks
11
Waitlist Control
Standard of care waitlist control group
15
Total26

Baseline characteristics

CharacteristicIyengar YogaWaitlist ControlTotal
Age, Continuous29.9 years
STANDARD_DEVIATION 2.9
27.1 years
STANDARD_DEVIATION 4.2
28.3 years
STANDARD_DEVIATION 3.9
Sex: Female, Male
Female
11 Participants15 Participants26 Participants
Sex: Female, Male
Male
0 Participants0 Participants0 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
— / —— / —
other
Total, other adverse events
0 / 110 / 15
serious
Total, serious adverse events
0 / 110 / 15

Outcome results

Primary

Disease Activity Scale (DAS)28

is a combined index that measures disease activity in patients with RA and remains a more thorough, established alternative to standard medical exams. This index includes a 28 tender joint count, 28 swollen joint count, Erythrocyte Sedimentation Rate (ESR), and general health assessment using a visual analogue scale. The ESR indirectly measures inflammation in the body and involves collecting blood samples, which will be performed by a qualified phlebotomist. The DAS score is a complicated formula based on many factors so there are no set ranges, but the published standards are as follows: A DAS28 score of higher than 5.1 is indicative of high disease activity, whereas a DAS28 below 3.2 indicates low disease activity. A patient is considered to be in remission if they have a DAS28 lower than 2.6. Source: DAS-Score.nl. Available at http://www.das-score.nl/www.das-score.nl/index.html. Accessed February 5, 2009.

Time frame: post intervention (within 2 weeks of completing intervention)

ArmMeasureValue (MEAN)Dispersion
Iyengar YogaDisease Activity Scale (DAS)283.3 units on a scaleStandard Deviation 1.2
Waitlist ControlDisease Activity Scale (DAS)283.3 units on a scaleStandard Deviation 1.6
Primary

Health Assessment Questionnaire (HAQ)

Items include questions about dressing and grooming, rising, eating, walking, hygiene, reaching, grip and making activities. The HAQ is one of the most widely recognized measures of patient functioning, with acceptable reliability and validity. It has been used successfully with adolescents as young as 13 years of age Range: 0-100, lower scores indicate better health

Time frame: post intervention (within 2 weeks of completing intervention)

ArmMeasureValue (MEAN)Dispersion
Iyengar YogaHealth Assessment Questionnaire (HAQ)31.5 units on a scaleStandard Deviation 28.5
Waitlist ControlHealth Assessment Questionnaire (HAQ)55.9 units on a scaleStandard Deviation 31.5
Primary

Health Related Quality of Life - Short Form-36 (SF-36)

The Health Related Quality of Life - Short Form-36 (SF-36) is a generic core HRQOL measure yielding an 8-scale profile of functional health and well being. The SF-36 performs comparatively better than other HRQOL measures in terms of reliability, validity, lightness of respondent/administrative burden. It can be completed in 5-10 minutes and has been used with children as young as 10 years of age. Subscales - all ranges 0-100 with higher scores indicating increased quality of life Bodily Pain, 2 items General Health, 5 items Vitality, 4 items Mental Health, 5 items

Time frame: post intervention (within 2 weeks of completing intervention)

ArmMeasureGroupValue (MEAN)Dispersion
Iyengar YogaHealth Related Quality of Life - Short Form-36 (SF-36)Bodily Pain Sub-Scale59.1 units on a scaleStandard Deviation 19.2
Iyengar YogaHealth Related Quality of Life - Short Form-36 (SF-36)General Health Sub-Scale60.1 units on a scaleStandard Deviation 21.4
Iyengar YogaHealth Related Quality of Life - Short Form-36 (SF-36)Vitality Sub-Scale64.5 units on a scaleStandard Deviation 12.3
Iyengar YogaHealth Related Quality of Life - Short Form-36 (SF-36)Mental Health Sub-Scale81.6 units on a scaleStandard Deviation 6.9
Waitlist ControlHealth Related Quality of Life - Short Form-36 (SF-36)Mental Health Sub-Scale67.8 units on a scaleStandard Deviation 19.5
Waitlist ControlHealth Related Quality of Life - Short Form-36 (SF-36)Bodily Pain Sub-Scale59.3 units on a scaleStandard Deviation 26.4
Waitlist ControlHealth Related Quality of Life - Short Form-36 (SF-36)Vitality Sub-Scale37.7 units on a scaleStandard Deviation 21.7
Waitlist ControlHealth Related Quality of Life - Short Form-36 (SF-36)General Health Sub-Scale47.0 units on a scaleStandard Deviation 16.7
Primary

Pain Disability Index (PDI)

The PDI assess the impact of pain on ability to participate in basic life activities, including social activity, sexual behavior, self-care and life-support activity. The PDI has been used with patients as young as 15. Good internal reliability (α = .82) and validity have been reported. It takes less than 5 minutes to complete. 7 items, total measure range: 0-70, higher scores = higher interference/disability

Time frame: post intervention (within 2 weeks of completing intervention)

ArmMeasureValue (MEAN)Dispersion
Iyengar YogaPain Disability Index (PDI)13.5 units on a scaleStandard Deviation 14.5
Waitlist ControlPain Disability Index (PDI)15.4 units on a scaleStandard Deviation 17.3

Source: ClinicalTrials.gov · Data processed: Mar 29, 2026